Bayer's Sebastian Guth at Endpoints #BIO22 (J.T. MacMillan Photography for Endpoints News)

Bay­er's re­search and de­vel­op­ment teams set­tle in­to new, $140M Kendall Square digs

Bay­er spent a con­sid­er­able amount of time dur­ing the pan­dem­ic — and $140 mil­lion in cash — to build out the top two floors at 238 Main Street at Kendall Square for its new US re­search cen­ter. And they pulled the wraps off this week to show off a new hub site that em­ploys all the buzzi­est ar­chi­tec­tur­al fea­tures in mod­ern of­fice and lab de­sign, from an open-space ap­proach to new lab­o­ra­to­ries for cell and tis­sue cul­ture ex­per­i­ments as well as chem­istry pro­teomics labs.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Vice President

Alexandria Real Estate Equities

San Francisco, CA, USA